Open57.660 | Close- |
Vol / Avg.4.440M / 10.669M | Mkt Cap119.549B |
Day Range57.120 - 58.050 | 52 Wk Range57.150 - 81.430 |
Bristol-Myers Squibb Stock (NYSE: BMY) stock price, news, charts, stock research, profile.
Open57.660 | Close- |
Vol / Avg.4.440M / 10.669M | Mkt Cap119.549B |
Day Range57.120 - 58.050 | 52 Wk Range57.150 - 81.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.800 | (EXPECTED) 2023-10-26 | |||||
REV | 11.010B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.980 | 1.750 | -0.2300 | ||||
REV | 11.810B | 11.226B | -584.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-15 | Truist Securities | Gregg Gilbert | Reiterates | BuyBuy | Maintains | - | 84.00 |
2023-09-15 | TD Cowen | Steve Scala | Maintains | Market PerformMarket Perform | Lowers | 80.00 | 66.00 |
2023-09-15 | Cantor Fitzgerald | Olivia Brayer | Reiterates | OverweightOverweight | Maintains | - | 75.00 |
2023-07-28 | Wells Fargo | Mohit Bansal | Maintains | Equal-WeightEqual-Weight | Lowers | 78.00 | 65.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BMY | Bristol-Myers Squibb | -1.08% | 119.5B |
NVO | Novo Nordisk | -4.78% | 391B |
JNJ | Johnson & Johnson | -0.4% | 372.1B |
MRK | Merck & Co | -1.34% | 256.7B |
NVS | Novartis | -1.82% | 206.2B |
You can purchase shares of Bristol-Myers Squibb (NYSE: BMY) through any online brokerage.
Other companies in Bristol-Myers Squibb’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Bristol-Myers Squibb (NYSE: BMY) was reported by Truist Securities on Friday, September 15, 2023. The analyst firm set a price target for 84.00 expecting BMY to rise to within 12 months (a possible 46.79% upside). 29 analyst firms have reported ratings in the last year.
The stock price for Bristol-Myers Squibb (NYSE: BMY) is $57.225 last updated Today at October 3, 2023 at 4:45 PM UTC.
The next Bristol-Myers Squibb (BMY) dividend date is projected to be Thursday, October 5, 2023.
Bristol-Myers Squibb’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bristol-Myers Squibb.
Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Bristol-Myers Squibb Stock (NYSE: BMY) stock price, news, charts, stock research, profile.
Open57.660 | Close- |
Vol / Avg.4.440M / 10.669M | Mkt Cap119.549B |
Day Range57.120 - 58.050 | 52 Wk Range57.150 - 81.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.800 | (EXPECTED) 2023-10-26 | |||||
REV | 11.010B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.980 | 1.750 | -0.2300 | ||||
REV | 11.810B | 11.226B | -584.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-15 | Truist Securities | Gregg Gilbert | Reiterates | BuyBuy | Maintains | - | 84.00 |
2023-09-15 | TD Cowen | Steve Scala | Maintains | Market PerformMarket Perform | Lowers | 80.00 | 66.00 |
2023-09-15 | Cantor Fitzgerald | Olivia Brayer | Reiterates | OverweightOverweight | Maintains | - | 75.00 |
2023-07-28 | Wells Fargo | Mohit Bansal | Maintains | Equal-WeightEqual-Weight | Lowers | 78.00 | 65.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BMY | Bristol-Myers Squibb | -1.08% | 119.5B |
NVO | Novo Nordisk | -4.78% | 391B |
JNJ | Johnson & Johnson | -0.4% | 372.1B |
MRK | Merck & Co | -1.34% | 256.7B |
NVS | Novartis | -1.82% | 206.2B |
You can purchase shares of Bristol-Myers Squibb (NYSE: BMY) through any online brokerage.
Other companies in Bristol-Myers Squibb’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Bristol-Myers Squibb (NYSE: BMY) was reported by Truist Securities on Friday, September 15, 2023. The analyst firm set a price target for 84.00 expecting BMY to rise to within 12 months (a possible 46.79% upside). 29 analyst firms have reported ratings in the last year.
The stock price for Bristol-Myers Squibb (NYSE: BMY) is $57.225 last updated Today at October 3, 2023 at 4:45 PM UTC.
The next Bristol-Myers Squibb (BMY) dividend date is projected to be Thursday, October 5, 2023.
Bristol-Myers Squibb’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bristol-Myers Squibb.
Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Bristol-Myers Squibb Stock (NYSE: BMY) stock price, news, charts, stock research, profile.
Open57.660 | Close- |
Vol / Avg.4.440M / 10.669M | Mkt Cap119.549B |
Day Range57.120 - 58.050 | 52 Wk Range57.150 - 81.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.800 | (EXPECTED) 2023-10-26 | |||||
REV | 11.010B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.980 | 1.750 | -0.2300 | ||||
REV | 11.810B | 11.226B | -584.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-15 | Truist Securities | Gregg Gilbert | Reiterates | BuyBuy | Maintains | - | 84.00 |
2023-09-15 | TD Cowen | Steve Scala | Maintains | Market PerformMarket Perform | Lowers | 80.00 | 66.00 |
2023-09-15 | Cantor Fitzgerald | Olivia Brayer | Reiterates | OverweightOverweight | Maintains | - | 75.00 |
2023-07-28 | Wells Fargo | Mohit Bansal | Maintains | Equal-WeightEqual-Weight | Lowers | 78.00 | 65.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BMY | Bristol-Myers Squibb | -1.08% | 119.5B |
NVO | Novo Nordisk | -4.78% | 391B |
JNJ | Johnson & Johnson | -0.4% | 372.1B |
MRK | Merck & Co | -1.34% | 256.7B |
NVS | Novartis | -1.82% | 206.2B |
You can purchase shares of Bristol-Myers Squibb (NYSE: BMY) through any online brokerage.
Other companies in Bristol-Myers Squibb’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Bristol-Myers Squibb (NYSE: BMY) was reported by Truist Securities on Friday, September 15, 2023. The analyst firm set a price target for 84.00 expecting BMY to rise to within 12 months (a possible 46.79% upside). 29 analyst firms have reported ratings in the last year.
The stock price for Bristol-Myers Squibb (NYSE: BMY) is $57.225 last updated Today at October 3, 2023 at 4:45 PM UTC.
The next Bristol-Myers Squibb (BMY) dividend date is projected to be Thursday, October 5, 2023.
Bristol-Myers Squibb’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bristol-Myers Squibb.
Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Bristol-Myers Squibb Stock (NYSE: BMY) stock price, news, charts, stock research, profile.
Open57.660 | Close- |
Vol / Avg.4.440M / 10.669M | Mkt Cap119.549B |
Day Range57.120 - 58.050 | 52 Wk Range57.150 - 81.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.800 | (EXPECTED) 2023-10-26 | |||||
REV | 11.010B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.980 | 1.750 | -0.2300 | ||||
REV | 11.810B | 11.226B | -584.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-15 | Truist Securities | Gregg Gilbert | Reiterates | BuyBuy | Maintains | - | 84.00 |
2023-09-15 | TD Cowen | Steve Scala | Maintains | Market PerformMarket Perform | Lowers | 80.00 | 66.00 |
2023-09-15 | Cantor Fitzgerald | Olivia Brayer | Reiterates | OverweightOverweight | Maintains | - | 75.00 |
2023-07-28 | Wells Fargo | Mohit Bansal | Maintains | Equal-WeightEqual-Weight | Lowers | 78.00 | 65.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BMY | Bristol-Myers Squibb | -1.08% | 119.5B |
NVO | Novo Nordisk | -4.78% | 391B |
JNJ | Johnson & Johnson | -0.4% | 372.1B |
MRK | Merck & Co | -1.34% | 256.7B |
NVS | Novartis | -1.82% | 206.2B |
You can purchase shares of Bristol-Myers Squibb (NYSE: BMY) through any online brokerage.
Other companies in Bristol-Myers Squibb’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Bristol-Myers Squibb (NYSE: BMY) was reported by Truist Securities on Friday, September 15, 2023. The analyst firm set a price target for 84.00 expecting BMY to rise to within 12 months (a possible 46.79% upside). 29 analyst firms have reported ratings in the last year.
The stock price for Bristol-Myers Squibb (NYSE: BMY) is $57.225 last updated Today at October 3, 2023 at 4:45 PM UTC.
The next Bristol-Myers Squibb (BMY) dividend date is projected to be Thursday, October 5, 2023.
Bristol-Myers Squibb’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bristol-Myers Squibb.
Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Bristol-Myers Squibb Stock (NYSE: BMY) stock price, news, charts, stock research, profile.
Open57.660 | Close- |
Vol / Avg.4.440M / 10.669M | Mkt Cap119.549B |
Day Range57.120 - 58.050 | 52 Wk Range57.150 - 81.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.800 | (EXPECTED) 2023-10-26 | |||||
REV | 11.010B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.980 | 1.750 | -0.2300 | ||||
REV | 11.810B | 11.226B | -584.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-15 | Truist Securities | Gregg Gilbert | Reiterates | BuyBuy | Maintains | - | 84.00 |
2023-09-15 | TD Cowen | Steve Scala | Maintains | Market PerformMarket Perform | Lowers | 80.00 | 66.00 |
2023-09-15 | Cantor Fitzgerald | Olivia Brayer | Reiterates | OverweightOverweight | Maintains | - | 75.00 |
2023-07-28 | Wells Fargo | Mohit Bansal | Maintains | Equal-WeightEqual-Weight | Lowers | 78.00 | 65.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BMY | Bristol-Myers Squibb | -1.08% | 119.5B |
NVO | Novo Nordisk | -4.78% | 391B |
JNJ | Johnson & Johnson | -0.4% | 372.1B |
MRK | Merck & Co | -1.34% | 256.7B |
NVS | Novartis | -1.82% | 206.2B |
You can purchase shares of Bristol-Myers Squibb (NYSE: BMY) through any online brokerage.
Other companies in Bristol-Myers Squibb’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Bristol-Myers Squibb (NYSE: BMY) was reported by Truist Securities on Friday, September 15, 2023. The analyst firm set a price target for 84.00 expecting BMY to rise to within 12 months (a possible 46.79% upside). 29 analyst firms have reported ratings in the last year.
The stock price for Bristol-Myers Squibb (NYSE: BMY) is $57.225 last updated Today at October 3, 2023 at 4:45 PM UTC.
The next Bristol-Myers Squibb (BMY) dividend date is projected to be Thursday, October 5, 2023.
Bristol-Myers Squibb’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bristol-Myers Squibb.
Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Bristol-Myers Squibb Stock (NYSE: BMY) stock price, news, charts, stock research, profile.
Open57.660 | Close- |
Vol / Avg.4.440M / 10.669M | Mkt Cap119.549B |
Day Range57.120 - 58.050 | 52 Wk Range57.150 - 81.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.800 | (EXPECTED) 2023-10-26 | |||||
REV | 11.010B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.980 | 1.750 | -0.2300 | ||||
REV | 11.810B | 11.226B | -584.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-15 | Truist Securities | Gregg Gilbert | Reiterates | BuyBuy | Maintains | - | 84.00 |
2023-09-15 | TD Cowen | Steve Scala | Maintains | Market PerformMarket Perform | Lowers | 80.00 | 66.00 |
2023-09-15 | Cantor Fitzgerald | Olivia Brayer | Reiterates | OverweightOverweight | Maintains | - | 75.00 |
2023-07-28 | Wells Fargo | Mohit Bansal | Maintains | Equal-WeightEqual-Weight | Lowers | 78.00 | 65.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BMY | Bristol-Myers Squibb | -1.08% | 119.5B |
NVO | Novo Nordisk | -4.78% | 391B |
JNJ | Johnson & Johnson | -0.4% | 372.1B |
MRK | Merck & Co | -1.34% | 256.7B |
NVS | Novartis | -1.82% | 206.2B |
You can purchase shares of Bristol-Myers Squibb (NYSE: BMY) through any online brokerage.
Other companies in Bristol-Myers Squibb’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Bristol-Myers Squibb (NYSE: BMY) was reported by Truist Securities on Friday, September 15, 2023. The analyst firm set a price target for 84.00 expecting BMY to rise to within 12 months (a possible 46.79% upside). 29 analyst firms have reported ratings in the last year.
The stock price for Bristol-Myers Squibb (NYSE: BMY) is $57.225 last updated Today at October 3, 2023 at 4:45 PM UTC.
The next Bristol-Myers Squibb (BMY) dividend date is projected to be Thursday, October 5, 2023.
Bristol-Myers Squibb’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bristol-Myers Squibb.
Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Bristol-Myers Squibb Stock (NYSE: BMY) stock price, news, charts, stock research, profile.
Open57.660 | Close- |
Vol / Avg.4.440M / 10.669M | Mkt Cap119.549B |
Day Range57.120 - 58.050 | 52 Wk Range57.150 - 81.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.800 | (EXPECTED) 2023-10-26 | |||||
REV | 11.010B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.980 | 1.750 | -0.2300 | ||||
REV | 11.810B | 11.226B | -584.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-15 | Truist Securities | Gregg Gilbert | Reiterates | BuyBuy | Maintains | - | 84.00 |
2023-09-15 | TD Cowen | Steve Scala | Maintains | Market PerformMarket Perform | Lowers | 80.00 | 66.00 |
2023-09-15 | Cantor Fitzgerald | Olivia Brayer | Reiterates | OverweightOverweight | Maintains | - | 75.00 |
2023-07-28 | Wells Fargo | Mohit Bansal | Maintains | Equal-WeightEqual-Weight | Lowers | 78.00 | 65.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BMY | Bristol-Myers Squibb | -1.08% | 119.5B |
NVO | Novo Nordisk | -4.78% | 391B |
JNJ | Johnson & Johnson | -0.4% | 372.1B |
MRK | Merck & Co | -1.34% | 256.7B |
NVS | Novartis | -1.82% | 206.2B |
You can purchase shares of Bristol-Myers Squibb (NYSE: BMY) through any online brokerage.
Other companies in Bristol-Myers Squibb’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Bristol-Myers Squibb (NYSE: BMY) was reported by Truist Securities on Friday, September 15, 2023. The analyst firm set a price target for 84.00 expecting BMY to rise to within 12 months (a possible 46.79% upside). 29 analyst firms have reported ratings in the last year.
The stock price for Bristol-Myers Squibb (NYSE: BMY) is $57.225 last updated Today at October 3, 2023 at 4:45 PM UTC.
The next Bristol-Myers Squibb (BMY) dividend date is projected to be Thursday, October 5, 2023.
Bristol-Myers Squibb’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bristol-Myers Squibb.
Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Bristol-Myers Squibb Stock (NYSE: BMY) stock price, news, charts, stock research, profile.
Open57.660 | Close- |
Vol / Avg.4.440M / 10.669M | Mkt Cap119.549B |
Day Range57.120 - 58.050 | 52 Wk Range57.150 - 81.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.800 | (EXPECTED) 2023-10-26 | |||||
REV | 11.010B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.980 | 1.750 | -0.2300 | ||||
REV | 11.810B | 11.226B | -584.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-15 | Truist Securities | Gregg Gilbert | Reiterates | BuyBuy | Maintains | - | 84.00 |
2023-09-15 | TD Cowen | Steve Scala | Maintains | Market PerformMarket Perform | Lowers | 80.00 | 66.00 |
2023-09-15 | Cantor Fitzgerald | Olivia Brayer | Reiterates | OverweightOverweight | Maintains | - | 75.00 |
2023-07-28 | Wells Fargo | Mohit Bansal | Maintains | Equal-WeightEqual-Weight | Lowers | 78.00 | 65.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BMY | Bristol-Myers Squibb | -1.08% | 119.5B |
NVO | Novo Nordisk | -4.78% | 391B |
JNJ | Johnson & Johnson | -0.4% | 372.1B |
MRK | Merck & Co | -1.34% | 256.7B |
NVS | Novartis | -1.82% | 206.2B |
You can purchase shares of Bristol-Myers Squibb (NYSE: BMY) through any online brokerage.
Other companies in Bristol-Myers Squibb’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Bristol-Myers Squibb (NYSE: BMY) was reported by Truist Securities on Friday, September 15, 2023. The analyst firm set a price target for 84.00 expecting BMY to rise to within 12 months (a possible 46.79% upside). 29 analyst firms have reported ratings in the last year.
The stock price for Bristol-Myers Squibb (NYSE: BMY) is $57.225 last updated Today at October 3, 2023 at 4:45 PM UTC.
The next Bristol-Myers Squibb (BMY) dividend date is projected to be Thursday, October 5, 2023.
Bristol-Myers Squibb’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bristol-Myers Squibb.
Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Bristol-Myers Squibb Stock (NYSE: BMY) stock price, news, charts, stock research, profile.
Open57.660 | Close- |
Vol / Avg.4.440M / 10.669M | Mkt Cap119.549B |
Day Range57.120 - 58.050 | 52 Wk Range57.150 - 81.430 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.800 | (EXPECTED) 2023-10-26 | |||||
REV | 11.010B |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.980 | 1.750 | -0.2300 | ||||
REV | 11.810B | 11.226B | -584.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-15 | Truist Securities | Gregg Gilbert | Reiterates | BuyBuy | Maintains | - | 84.00 |
2023-09-15 | TD Cowen | Steve Scala | Maintains | Market PerformMarket Perform | Lowers | 80.00 | 66.00 |
2023-09-15 | Cantor Fitzgerald | Olivia Brayer | Reiterates | OverweightOverweight | Maintains | - | 75.00 |
2023-07-28 | Wells Fargo | Mohit Bansal | Maintains | Equal-WeightEqual-Weight | Lowers | 78.00 | 65.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
BMY | Bristol-Myers Squibb | -1.08% | 119.5B |
NVO | Novo Nordisk | -4.78% | 391B |
JNJ | Johnson & Johnson | -0.4% | 372.1B |
MRK | Merck & Co | -1.34% | 256.7B |
NVS | Novartis | -1.82% | 206.2B |
You can purchase shares of Bristol-Myers Squibb (NYSE: BMY) through any online brokerage.
Other companies in Bristol-Myers Squibb’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Bristol-Myers Squibb (NYSE: BMY) was reported by Truist Securities on Friday, September 15, 2023. The analyst firm set a price target for 84.00 expecting BMY to rise to within 12 months (a possible 46.79% upside). 29 analyst firms have reported ratings in the last year.
The stock price for Bristol-Myers Squibb (NYSE: BMY) is $57.225 last updated Today at October 3, 2023 at 4:45 PM UTC.
The next Bristol-Myers Squibb (BMY) dividend date is projected to be Thursday, October 5, 2023.
Bristol-Myers Squibb’s Q3 earnings are confirmed for Thursday, October 26, 2023.
There is no upcoming split for Bristol-Myers Squibb.
Bristol-Myers Squibb is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.